Search Results - "Péter, Klivényi"

Refine Results
  1. 1

    Effect of 3-nitropropionic acid on sirtuin gene expression in Sirt3 deficient mice by Horváth, Orsolya, Klivényi, Péter

    Published in Neuroscience letters (27-07-2024)
    “…Huntington’s disease (HD) is an autosomal inherited progressive neurodegenerative disorder which is caused by the CAG trinucleotide repeat in the huntingtin…”
    Get full text
    Journal Article
  2. 2

    Real-world user experience with seizure detection wearable devices in the home environment by Hadady, Levente, Klivényi, Péter, Fabó, Dániel, Beniczky, Sándor

    Published in Epilepsia (Copenhagen) (01-12-2023)
    “…To evaluate direct user experience with wearable seizure detection devices in the home environment. A structured online questionnaire was completed by 242…”
    Get full text
    Journal Article
  3. 3

    Gene variants and expression changes of SIRT1 and SIRT6 in peripheral blood are associated with Parkinson’s disease by Maszlag-Török, Rita, Boros, Fanni A., Vécsei, László, Klivényi, Péter

    Published in Scientific reports (21-05-2021)
    “…Parkinson’s disease (PD) is a neurodegenerative disease caused by complex interaction between genetic and environmental factors. There is a growing body of…”
    Get full text
    Journal Article
  4. 4

    Frontal two-electrode transcranial direct current stimulation protocols may not affect performance on a combined flanker Go/No-Go task by Holczer, Adrienn, Vékony, Teodóra, Klivényi, Péter, Must, Anita

    Published in Scientific reports (24-07-2023)
    “…Transcranial direct current stimulation (tDCS) has been tested to modulate cognitive control or response inhibition using various electrode montages. However,…”
    Get full text
    Journal Article
  5. 5

    Increased level of NEAT1 long non-coding RNA is detectable in peripheral blood cells of patients with Parkinson’s disease by Boros, Fanni Annamária, Maszlag-Török, Rita, Vécsei, László, Klivényi, Péter

    Published in Brain research (01-03-2020)
    “…•NEAT1 lncRNA regulates cellular and mitochondrial homeostasis.•Changes in NEAT1 level were reported in PD brain and in models of the disease.•We detected…”
    Get full text
    Journal Article
  6. 6

    Proteomics in Multiple Sclerosis: The Perspective of the Clinician by Sandi, Dániel, Kokas, Zsófia, Biernacki, Tamás, Bencsik, Krisztina, Klivényi, Péter, Vécsei, László

    “…Multiple sclerosis (MS) is the inflammatory demyelinating and neurodegenerative disease of the central nervous system (CNS) that affects approximately 2.8…”
    Get full text
    Journal Article
  7. 7

    Neuroprotection in Parkinson’s disease: facts and hopes by Salamon, András, Zádori, Dénes, Szpisjak, László, Klivényi, Péter, Vécsei, László

    Published in Journal of Neural Transmission (01-05-2020)
    “…Parkinson’s disease (PD) is the second most common neurodegenerative disease worldwide. Behind the symptoms there is a complex pathological mechanism which…”
    Get full text
    Journal Article
  8. 8

    Non-invasive Brain Stimulation in Alzheimer's Disease and Mild Cognitive Impairment-A State-of-the-Art Review on Methodological Characteristics and Stimulation Parameters by Holczer, Adrienn, Németh, Viola Luca, Vékony, Teodóra, Vécsei, László, Klivényi, Péter, Must, Anita

    Published in Frontiers in human neuroscience (25-05-2020)
    “…Transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) have been proposed as a new therapeutic way to enhance the cognition…”
    Get full text
    Journal Article
  9. 9

    The effect of computerized cognitive training and transcranial direct current stimulation on working memory among post-stroke individuals: a systematic review with meta-analysis and meta-regression by Kazinczi, Csaba, Kocsis, Krisztián, Boross, Katalin, Racsmány, Mihály, Klivényi, Péter, Vécsei, László, Must, Anita

    Published in BMC neurology (04-09-2024)
    “…Working memory (WM) impairment is a common phenomenon after stroke; however, its management in rehabilitation is less researched. This systematic review and…”
    Get full text
    Journal Article
  10. 10

    Monotherapy with infusion therapies – useful or not? by Rožanković, Petra Bago, Johansson, Anders, Péter, Klivényi, Milanov, Ivan, Odin, Per

    Published in Journal of Neural Transmission (01-11-2024)
    “…Infusion pump-based therapies are an effective treatment option for patients with advanced Parkinson´s disease. Achieving monotherapy with infusion-based…”
    Get full text
    Journal Article
  11. 11

    Opicapone for the treatment of Parkinson's disease: an update by Salamon, András, Zádori, Dénes, Szpisjak, László, Klivényi, Péter, Vécsei, László

    Published in Expert opinion on pharmacotherapy (12-12-2019)
    “…: Parkinson's disease is a neurodegenerative disorder which is characterized by the combination of motor and non-motor symptoms. As yet, there is no curative…”
    Get more information
    Journal Article
  12. 12

    The genetic background of Parkinson's disease and novel therapeutic targets by Salamon, András, Zádori, Dénes, Szpisjak, László, Klivényi, Péter, Vécsei, László

    Published in Expert opinion on therapeutic targets (03-10-2022)
    “…Parkinson's disease (PD) is the second most common neurodegenerative disease worldwide. The median age of disease onset is around 60 years. From a genetic…”
    Get more information
    Journal Article
  13. 13

    Examining the Prevalence of Left Atrial Appendage Thrombus in a Cohort of Acute Stroke Patients with an Extended Computed Tomography Angiographic Protocol by Antal, Szabolcs István, Szabó, Nikoletta, Klucsai, Róbert, Klivényi, Péter, Kincses, Zsigmond Támas

    Published in European neurology (2024)
    “…Current guidelines recommend transthoracic echocardiography (TTE) for routine screening of cardiac emboli; however, the visualization of the left atrial…”
    Get more information
    Journal Article
  14. 14

    Rare co-occurrence of multiple sclerosis and Wilson's disease - case report by Despotov, Katalin, Klivényi, Péter, Nagy, István, Pálvölgyi, Attila, Vécsei, László, Rajda, Cecília

    Published in BMC neurology (16-05-2022)
    “…Wilson's disease is a hereditary disorder of copper metabolism resulting mainly in hepatic, neurological, and psychiatric symptoms. Multiple sclerosis (MS) is…”
    Get full text
    Journal Article
  15. 15

    Beyond C9orf72: repeat expansions and copy number variations as risk factors of amyotrophic lateral sclerosis across various populations by Nagy, Zsófia Flóra, Pál, Margit, Engelhardt, József I, Molnár, Mária Judit, Klivényi, Péter, Széll, Márta

    Published in BMC medical genomics (22-01-2024)
    “…Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder which is characterized by the loss of both upper and lower motor neurons in the central…”
    Get full text
    Journal Article
  16. 16

    NEAT1 on the Field of Parkinson's Disease: Offense, Defense, or a Player on the Bench? by Boros, Fanni Annamária, Vécsei, László, Klivényi, Péter

    Published in Journal of Parkinson's disease (01-01-2021)
    “…Parkinson's disease (PD) is the second most common neurodegenerative disease worldwide. Considering the devastating symptoms, high prevalence, and lack of…”
    Get more information
    Journal Article
  17. 17

    Comprehensive Genetic Analysis of a Hungarian Amyotrophic Lateral Sclerosis Cohort by Tripolszki, Kornélia, Gampawar, Piyush, Schmidt, Helena, Nagy, Zsófia F, Nagy, Dóra, Klivényi, Péter, Engelhardt, József I, Széll, Márta

    Published in Frontiers in genetics (16-08-2019)
    “…Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by the degeneration of motor neurons. Genetic factors play a key…”
    Get full text
    Journal Article
  18. 18

    Fixed-dose combination therapy for Parkinson's disease with a spotlight on entacapone in the past 20 years: a reduced pill burden and a simplified dosing regime by Salamon, András, Zádori, Dénes, Szpisjak, László, Klivényi, Péter, Vécsei, László

    Published in Expert opinion on pharmacotherapy (11-12-2020)
    “…Parkinson's disease (PD) is a progressive, chronic neurodegenerative disorder. The main neuropathological cause of the disease is the death of dopaminergic…”
    Get more information
    Journal Article
  19. 19

    Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: Novel therapeutic strategies for neurodegenerative disorders by Zádori, Dénes, Klivényi, Péter, Szalárdy, Levente, Fülöp, Ferenc, Toldi, József, Vécsei, László

    Published in Journal of the neurological sciences (15-11-2012)
    “…Abstract A mitochondrial dysfunction causes an abatement in ATP production, the induction of oxidative damage and the propagation of cell death pathways. It is…”
    Get full text
    Journal Article
  20. 20

    DWI-FLAIR mismatch guided thrombolysis in patients without large-vessel occlusion: real-world data from a comprehensive stroke centre by Annus, Ádám, Gera, Franciska Zita, Sztriha, László, Klivényi, Péter

    Published in Heliyon (01-12-2022)
    “…A significant proportion of ischaemic stroke patients present with unknown symptom onset time. DWI-FLAIR mismatch on MRI can help to identify those eligible…”
    Get full text
    Journal Article